Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications - ScienceDirect
Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System: JACC Review Topic of the Week | Journal of the American College of Cardiology
Coronavirus Disease 2019 (COVID‐19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 ...
SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications - ScienceDirect
COVID-19 and the Renin-Angiotensin System - Kidney International Reports
ACEI/ARB therapy in COVID-19: the double-edged sword of ACE2 and SARS-CoV-2 viral docking | Critical Care | Full Text
COVID-19 and ACE -inhibitors and angiotensin receptor blockers-: The need to differentiate between early infection and acute lung injury | Revista Colombiana de Cardiología
COVID-19: The Influence of ACE Genotype and ACE-I and ARBs on the Cour | CIA
ACE2 as a potential therapeutic target for pandemic COVID-19 - RSC Advances (RSC Publishing) DOI:10.1039/D0RA08228G
Frontiers | Role of Renin-Angiotensin System Components in Atherosclerosis: Focus on Ang-II, ACE2, and Ang-1–7
SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy - eBioMedicine
ACE inhibitors, angiotensin receptor blockers and endothelial injury in COVID‐19 - Tetlow - 2021 - Journal of Internal Medicine - Wiley Online Library
Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic | Nature Reviews Nephrology
ACE Inhibitor Pathway, Pharmacodynamics
COVID‐19 and renin‐angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) ‐ Is there any scientific evidence for controversy? - Aleksova - 2020 - Journal of Internal Medicine - Wiley Online Library
Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine
Determining available strategies for prevention and therapy: Exploring COVID‑19 from the perspective of ACE2 (Review)
Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease
The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19: Molecular Therapy - Methods & Clinical Development
IJMS | Free Full-Text | Do Changes in ACE-2 Expression Affect SARS-CoV-2 Virulence and Related Complications: A Closer Look into Membrane-Bound and Soluble Forms
Allosteric Site of ACE-2 as a Drug Target for COVID-19 | ACS Pharmacology & Translational Science
Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19 | NEJM
